Guido Marcucci, M.D.
- Chair and Professor, Department of Hematologic Malignancies Translational Science
- Director, Gehr Family Center for Leukemia Research
- Professor, Department of Hematology & Hematopoietic Cell Transplantation
- Hematologist/Oncologist
800-826-4673
View Research Profile
Guido Marcucci, M.D.
Clinical Specialties
- Hematology/Oncology
Areas of Expertise
- Leukemia
- Acute myeloid leukemia
Research Focus
- Biology and treatment of acute leukemia and myelodysplastic syndrome
Other Languages Spoken
- Italian
“I have always been interested in answering the fundamental questions of what events initiate cancer, and I believe that leukemia can be used as a model to answer these questions.”
Guido Marcucci, M.D., thinks of acute myeloid leukemia (AML) as the “prototype of cancer and how cancer develops,” which makes it a prime target for intensive research, and the focus of much of Dr. Marcucci's distinguished career.
Dr. Marcucci joined City of Hope in 2014 from Ohio State University, where he was a professor of internal medicine, molecular virology, immunology, medical genetics and pharmaceutics in the division of hematology at the university’s comprehensive cancer center.
At City of Hope, Dr. Marcucci is playing a key role in our efforts to further expand and broaden our world-renowned work in leukemia research and treatment. He directs the Gehr Family Center for Leukemia Research and serves as chair of the Department of Hematologic Malignancies Translational Science.
A nationally-recognized authority on leukemia, Dr. Marcucci has lectured around the world and authored more than 270 scholarly papers on the subject. His ultimate goal is to make leukemia a thing of the past. He has received numerous competitive NCI grants for his clinical and research work focused on the pathogenesis, treatment and prognostic assessment of patients with acute myeloid leukemia. Dr. Marcucci currently serves on the editorial board of three journals, including Blood and the Journal of Clinical Oncology.
“I know what a devastating disease leukemia can be for patients and their families,” he says. “I would love one day to be able to say that I helped to alleviate their suffering.”
- 2017 - Present, Chair and Professor, Department of Hematologic Malignancies Translational Science, Beckman Research Institute of City of Hope, Duarte, CA
- 2014 - Present, Associate Director of Basic Research, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
- 2014 - Present, Professor, Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
- 2009 - 2014, Professor of Internal Medicine and Molecular Virology, Immunology and Medical Genetics, and Pharmaceutics Division Hematology, Comprehensive Cancer Center and Ohio State University, Columbus, OH
- Hematology & Hematopoietic Cell Transplantation
- Leukemia
- Acute Myeloid Leukemia
Degrees
- 1986 - M.D. Catholic University of the Sacred Heart, Rome Italy
Fellowship
- 1995 – 1997, Medical Oncology Fellowship, Dept. of Medicine, Roswell Park Cancer Institute, Buffalo, N.Y.
- 1990, Internal Medicine Fellowship, Regione Lazio, Italy
Residency
- 1990 – 1993, Internship and Residency in Internal Medicine, State University of New York, Buffalo, N.Y.
- 1986 –1989 Residency in Dermatology, Dept. of Dermatology, Catholic University of the Sacred Heart, Rome, Italy
Internship
- 1990 –1993, Internship and Residency in Internal Medicine, State University of New York, Buffalo, N.Y.
- Internal Medicine
- Oncology
New Researcher Takes Aim at Acute Myeloid Leukemia
February 27, 2018
Leukemia 2016: More treatments will target leukemia by type
December 31, 2016
Acute myeloid leukemia: What you should know (w/PODCAST)
August 24, 2015
City of Hope launches institute focused on hematologic malignancies
October 28, 2014
Information listed here is obtained from Pubmed, a public database; City of Hope is not responsible for its accuracy.
- American Association for Cancer Research
- American Society of Clinical Oncology
- American Society of Hematology